Theravance Bio: Q2 Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Theravance Biopharma Inc. (TBPH) on Monday reported a loss of $5.9 million in its second quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of 11 cents. Earnings, adjusted for non-recurring costs and stock option expense, were 19 cents per share.

The biopharmaceutical company posted revenue of $20.7 million in the period, topping Street forecasts. Three analysts surveyed by Zacks expected $19.8 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TBPH at https://www.zacks.com/ap/TBPH